# The Safety and Microbial Changes in the Use of Intranasal Neosporin®

> **NCT07698938** · NA · COMPLETED · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 12 (actual)

## Conditions studied

- Teste the Safety of (Polymyxin B Sulfate 500,000 IU, Bacitracin Zinc 40,000 IU, Neomycin Sulfate 0.35g Neomycin Base) Intranasally

## Interventions

- **DRUG:** Intranasal application of Polymyxin B Sulfate 500,000 IU, Bacitracin zinc 40,000 IU, Neomycin Sulfate 0.35g neomycin base

## Key facts

- **NCT ID:** NCT07698938
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-13
- **Primary completion:** 2025-03-22
- **Final completion:** 2025-03-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698938, "The Safety and Microbial Changes in the Use of Intranasal Neosporin®". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*